| Literature DB >> 35891243 |
Vittoria Franchina1, Rubinia Celeste Bonfanti2, Gianluca Lo Coco2, Laura Salerno2.
Abstract
Recent studies have suggested that health constructs embraced by the Terror Management Theory (TMT) and the Basic Psychological Needs Theory (BPNT) may drive individuals' COVID-19 health-related decisions. This study examines the relationships between existential concerns (ECs; within the TMT), basic psychological needs (BPNs; within the BPNT) and COVID-19 vaccine hesitancy (VH), as well as the mediating role of negative attitudes toward COVID-19 vaccines. A cross-sectional survey was carried out from April to May 2021 on a sample of two hundred and eighty-seven adults (Mage = 36.04 ± 12.07; 59.9% females). Participants provided information regarding existential concerns, basic psychological needs, attitudes toward COVID-19 vaccines and vaccine hesitancy for Pfizer-BioNTech and AstraZeneca vaccines separately. Higher vaccine hesitancy (32.1%) and vaccine resistance (32.8%) rates were found for AstraZeneca than for Pfizer-BioNTech COVID-19 vaccine (22.3% and 10.1%, respectively). Structural equation modeling showed that existential concerns were related to Pfizer-BioNTech and AstraZeneca vaccine hesitancy both directly and indirectly through negative attitudes toward potential side effects of COVID-19 vaccines. The findings of the study confirm that the TMT is efficient in explaining COVID-19 vaccine hesitancy. Targeted efforts are needed to increase the acceptance of COVID-19 vaccines.Entities:
Keywords: AstraZeneca vaccine; COVID-19; Pfizer-BioNTech vaccine; attitudes; basic psychological needs; existential concerns; vaccine hesitancy
Year: 2022 PMID: 35891243 PMCID: PMC9319079 DOI: 10.3390/vaccines10071079
Source DB: PubMed Journal: Vaccines (Basel) ISSN: 2076-393X
Participants’ demographics and health-related data and descriptive statistics for the study variables.
| Sample ( | |
|---|---|
| Age, M (SD) | 36.04 (12.07) |
| Gender, | 172 (59.9) |
| Educational level, | |
| 13 years of schooling | 134 (46.7) |
| Degree/post-graduate | 149 (51.9) |
| missing | 4 (1.4) |
| Italian regions, | |
| Northern | 99 (34.5) |
| Central | 48 (16.7) |
| Southern | 125 (43.6) |
| missing | 15 (5.2) |
| Pathologies, | 35 (12.2) |
| Own diagnosis of COVID-19, | 20 (7.0) |
| COVID-19 among relatives, | 140 (48.8) |
| ECs—General Existential Concerns, M (SD) | 30.71 (11.41) |
| ECs—Death Anxiety, M (SD) | 15.57 (6.35) |
| ECs—Avoidance, M (SD) | 9.45 (3.95) |
| BPNs—Autonomy, M (SD) | 9.42 (3.13) |
| BPNs—Competence, M (SD) | 9.59 (3.17) |
| BPNs—Relatedness, M (SD) | 10.01 (3.17) |
| Attitudes toward vaccine—WRK, M (SD) | 6.73 (2.22) |
| Attitudes toward vaccine—SE, M (SD) | 7.73 (4.26) |
| VH—Pfizer-BioNTech, M (SD) | 3.88 (1.31) |
| VH—AstraZeneca, M (SD) | 2.72 (1.50) |
Note: ECs = Existential concerns; BPNs = Basic Psychological Needs; WRK = Attitude toward COVID-19 vaccines—vaccine will be effective; SE = Attitude toward COVID-19 vaccines—side effects; VH = Vaccine Hesitancy.
Figure 1Theoretical model of the study.
Parameter estimates from the structural equation modeling for existential concerns, basic psychological needs, attitudes toward COVID-19 vaccines and vaccine hesitancy.
| Model | β | SE | 95% CI | |
|---|---|---|---|---|
| Direct paths | ||||
| ECs → WRK | 0.137 | 0.015 | 0.047 | 0.005/0.054 |
| ECs → SE | 0.161 | 0.027 | 0.015 | 0.022/0.112 |
| BPNs → WRK | 0.094 | 0.075 | 0.226 | −0.032/0.213 |
| BPNs → SE | −0.085 | 0.138 | 0.254 | −0.383/0.066 |
| ECs → VH AstraZeneca | 0.132 | 0.009 | 0.045 | 0.003/0.034 |
| ECs → VH Pfizer-BioNTech | 0.138 | 0.007 | 0.017 | 0.006/0.030 |
| BPNs → VH AstraZeneca | −0.064 | 0.045 | 0.353 | −0.116/0.029 |
| BPNs → VH Pfizer-BioNTech | 0.040 | 0.036 | 0.523 | −0.036/0.082 |
| WRK → VH AstraZeneca | 0.024 | 0.041 | 0.700 | −0.055/0.081 |
| WRK → VH Pfizer-BioNTech | −0.094 | 0.043 | 0.192 | −0.127/0.012 |
| SE → VH AstraZeneca | −0.366 | 0.018 | 0.000 | −0.158/−0.098 |
| SE → VH Pfizer-BioNTech | −0.392 | 0.018 | 0.000 | −0.150/−0.090 |
| Indirect paths | ||||
| ECs → WRK → VH AstraZeneca | 0.003 | 0.010 | 0.737 | −0.013/0.019 |
| ECs → WRK → VH Pfizer-BioNTech | −0.013 | 0.013 | 0.318 | −0.034 /0.008 |
| ECs → SE → VH AstraZeneca | −0.059 | 0.026 | 0.021 | −0.101/−0.017 |
| ECs → SE → VH Pfizer-BioNTech | −0.063 | 0.028 | 0.025 | −0.110/−0.017 |
| BPNs → WRK → VH AstraZeneca | 0.002 | 0.008 | 0.777 | −0.011/0.015 |
| BPNs → WRK → VH Pfizer-BioNTech | −0.009 | 0.012 | 0.446 | −0.028/0.010 |
| BPNs → SE → VH AstraZeneca | 0.031 | 0.028 | 0.259 | −0.014/0.077 |
| BPNs → SE → VH Pfizer-BioNTech | 0.033 | 0.030 | 0.258 | −0.015/0.082 |
| Correlations | ||||
| WRK with SE | 0.339 | 0.577 | 0.000 | 2.139/4.010 |
| VH AstraZeneca with VH Pfizer-BioNTech | 0.438 | 0.096 | 0.000 | 0.549/0.869 |
Note. ECs = Existential Concerns; BPNs = Basic Psychological Needs; WRK = Attitude toward COVID-19 vaccines—vaccine will be effective; SE = Attitude toward COVID-19 vaccines—side effects; VH = Vaccine Hesitancy.
Figure 2Structural equation modeling testing attitudes towards COVID-19 vaccines as a mediator of the relationship among ECs, BPNs and Pfizer-BioNTech and AstraZeneca VH. Note. ECs = Existential Concerns; BPNs = Basic Psychological Needs; WRK = Attitude toward COVID-19 vaccines—vaccine will be effective; SE = Attitude toward COVID-19 vaccines—side effects; VH = Vaccine Hesitancy; Errors and correlations were omitted from the diagram for clarity; Non-significant paths are represented by grey dashed lines; Significant paths are represented by black solid lines.